China's National Medical Products Administration (NMPA) has approved Keymed Biosciences’ supplemental new drug application ...

Aclaris' stock has dropped nearly 70% since September 2023, reflecting its history of failures and dissipations. Explore more ...

For some people, the classic symptoms of a sinus infection, including nasal congestion and discharge, are also accompanied by ...